206 related articles for article (PubMed ID: 32626544)
1. An assessment of mutagenicity of chemical substances by (quantitative) structure-activity relationship.
Honma M
Genes Environ; 2020; 42():23. PubMed ID: 32626544
[TBL] [Abstract][Full Text] [Related]
2. Screening for Ames mutagenicity of food flavor chemicals by (quantitative) structure-activity relationship.
Honma M; Kitazawa A; Kasamatsu T; Sugiyama KI
Genes Environ; 2020 Nov; 42(1):32. PubMed ID: 33292765
[TBL] [Abstract][Full Text] [Related]
3. Improvement of quantitative structure-activity relationship (QSAR) tools for predicting Ames mutagenicity: outcomes of the Ames/QSAR International Challenge Project.
Honma M; Kitazawa A; Cayley A; Williams RV; Barber C; Hanser T; Saiakhov R; Chakravarti S; Myatt GJ; Cross KP; Benfenati E; Raitano G; Mekenyan O; Petkov P; Bossa C; Benigni R; Battistelli CL; Giuliani A; Tcheremenskaia O; DeMeo C; Norinder U; Koga H; Jose C; Jeliazkova N; Kochev N; Paskaleva V; Yang C; Daga PR; Clark RD; Rathman J
Mutagenesis; 2019 Mar; 34(1):3-16. PubMed ID: 30357358
[TBL] [Abstract][Full Text] [Related]
4. Transitioning to composite bacterial mutagenicity models in ICH M7 (Q)SAR analyses.
Landry C; Kim MT; Kruhlak NL; Cross KP; Saiakhov R; Chakravarti S; Stavitskaya L
Regul Toxicol Pharmacol; 2019 Dec; 109():104488. PubMed ID: 31586682
[TBL] [Abstract][Full Text] [Related]
5. The importance of expert review to clarify ambiguous situations for (Q)SAR predictions under ICH M7.
Foster RS; Fowkes A; Cayley A; Thresher A; Werner AD; Barber CG; Kocks G; Tennant RE; Williams RV; Kane S; Stalford SA
Genes Environ; 2020; 42():27. PubMed ID: 32983286
[TBL] [Abstract][Full Text] [Related]
6. A practice of expert review by read-across using QSAR Toolbox.
Fukuchi J; Kitazawa A; Hirabayashi K; Honma M
Mutagenesis; 2019 Mar; 34(1):49-54. PubMed ID: 30690463
[TBL] [Abstract][Full Text] [Related]
7. Predicting the mutagenic potential of chemicals in tobacco products using
Goel R; Valerio LG
Toxicol Mech Methods; 2020 Nov; 30(9):672-678. PubMed ID: 32752976
[TBL] [Abstract][Full Text] [Related]
8. Mutagenicity assessment strategy for pharmaceutical intermediates to aid limit setting for occupational exposure.
Araya S; Lovsin-Barle E; Glowienke S
Regul Toxicol Pharmacol; 2015 Nov; 73(2):515-20. PubMed ID: 26454093
[TBL] [Abstract][Full Text] [Related]
9. The Consultancy Activity on In Silico Models for Genotoxic Prediction of Pharmaceutical Impurities.
Pavan M; Kovarich S; Bassan A; Broccardo L; Yang C; Fioravanzo E
Methods Mol Biol; 2016; 1425():511-29. PubMed ID: 27311479
[TBL] [Abstract][Full Text] [Related]
10. Assessing the impact of expert knowledge on ICH M7 (Q)SAR predictions. Is expert review still needed?
Jayasekara PS; Skanchy SK; Kim MT; Kumaran G; Mugabe BE; Woodard LE; Yang J; Zych AJ; Kruhlak NL
Regul Toxicol Pharmacol; 2021 Oct; 125():105006. PubMed ID: 34273441
[TBL] [Abstract][Full Text] [Related]
11. (Q)SAR tools for priority setting: A case study with printed paper and board food contact material substances.
Van Bossuyt M; Van Hoeck E; Raitano G; Manganelli S; Braeken E; Ates G; Vanhaecke T; Van Miert S; Benfenati E; Mertens B; Rogiers V
Food Chem Toxicol; 2017 Apr; 102():109-119. PubMed ID: 28163056
[TBL] [Abstract][Full Text] [Related]
12. Performance of (Q)SAR models for predicting Ames mutagenicity of aryl azo and benzidine based compounds.
Kulkarni SA; Barton-Maclaren TS
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2014; 32(1):46-82. PubMed ID: 24598040
[TBL] [Abstract][Full Text] [Related]
13. Prediction of genotoxic potential of cosmetic ingredients by an in silico battery system consisting of a combination of an expert rule-based system and a statistics-based system.
Aiba née Kaneko M; Hirota M; Kouzuki H; Mori M
J Toxicol Sci; 2015 Feb; 40(1):77-98. PubMed ID: 25743748
[TBL] [Abstract][Full Text] [Related]
14. Principles and procedures for implementation of ICH M7 recommended (Q)SAR analyses.
Amberg A; Beilke L; Bercu J; Bower D; Brigo A; Cross KP; Custer L; Dobo K; Dowdy E; Ford KA; Glowienke S; Van Gompel J; Harvey J; Hasselgren C; Honma M; Jolly R; Kemper R; Kenyon M; Kruhlak N; Leavitt P; Miller S; Muster W; Nicolette J; Plaper A; Powley M; Quigley DP; Reddy MV; Spirkl HP; Stavitskaya L; Teasdale A; Weiner S; Welch DS; White A; Wichard J; Myatt GJ
Regul Toxicol Pharmacol; 2016 Jun; 77():13-24. PubMed ID: 26877192
[TBL] [Abstract][Full Text] [Related]
15. Carbamates and ICH M7 classification: Making use of expert knowledge.
Hemingway R; Fowkes A; Williams RV
Regul Toxicol Pharmacol; 2017 Jun; 86():392-401. PubMed ID: 28385577
[TBL] [Abstract][Full Text] [Related]
16. Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: A case study using aromatic amine mutagenicity.
Ahlberg E; Amberg A; Beilke LD; Bower D; Cross KP; Custer L; Ford KA; Van Gompel J; Harvey J; Honma M; Jolly R; Joossens E; Kemper RA; Kenyon M; Kruhlak N; Kuhnke L; Leavitt P; Naven R; Neilan C; Quigley DP; Shuey D; Spirkl HP; Stavitskaya L; Teasdale A; White A; Wichard J; Zwickl C; Myatt GJ
Regul Toxicol Pharmacol; 2016 Jun; 77():1-12. PubMed ID: 26879463
[TBL] [Abstract][Full Text] [Related]
17. (Q)SAR assessments of potentially mutagenic impurities: a regulatory perspective on the utility of expert knowledge and data submission.
Powley MW
Regul Toxicol Pharmacol; 2015 Mar; 71(2):295-300. PubMed ID: 25545315
[TBL] [Abstract][Full Text] [Related]
18. Establishing best practise in the application of expert review of mutagenicity under ICH M7.
Barber C; Amberg A; Custer L; Dobo KL; Glowienke S; Van Gompel J; Gutsell S; Harvey J; Honma M; Kenyon MO; Kruhlak N; Muster W; Stavitskaya L; Teasdale A; Vessey J; Wichard J
Regul Toxicol Pharmacol; 2015 Oct; 73(1):367-77. PubMed ID: 26248005
[TBL] [Abstract][Full Text] [Related]
19.
Benigni R; Bassan A; Pavan M
Expert Opin Drug Metab Toxicol; 2020 Aug; 16(8):651-662. PubMed ID: 32567390
[TBL] [Abstract][Full Text] [Related]
20. Use of in silico systems and expert knowledge for structure-based assessment of potentially mutagenic impurities.
Sutter A; Amberg A; Boyer S; Brigo A; Contrera JF; Custer LL; Dobo KL; Gervais V; Glowienke S; van Gompel J; Greene N; Muster W; Nicolette J; Reddy MV; Thybaud V; Vock E; White AT; Müller L
Regul Toxicol Pharmacol; 2013 Oct; 67(1):39-52. PubMed ID: 23669331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]